SUTIMLIMAB-JOME vs TAFAMIDIS: Which Drug Is Safer?
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
SUTIMLIMAB-JOME vs TAFAMIDIS: Safety Overview
| Metric | SUTIMLIMAB-JOME | TAFAMIDIS |
|---|---|---|
| Total FAERS Reports | 209 | 9,202 |
| Deaths Reported | 28 | 3,343 |
| Death Rate | 13.4% | 36.3% |
| Hospitalizations | 37 | 2,284 |
| Average Patient Age | 72.1 yrs | 80.7 yrs |
| % Female Patients | 69.9% | 20.7% |
| FDA Approval Date | N/A | May 3, 2019 |
| Manufacturer | N/A | Pfizer Laboratories Div Pfizer Inc |
| Marketing Status | Prescription | Prescription |